Keywords: Shire, Movetis, Firazyr, Second-quarter 2010 financial results

Shire says 2nd-qtr 2010 revenues rose 35% and EPS leapt 71%; updates on Firazyr; Movetis’ Resolor cleared in Switzerland

Article | 05 August 2010

Print This

UK specialty drugmaker Shire, which has moved its headquarters to Ireland for tax reasons, posted rocketing earnings and revenues for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in